About
ReGEN Biomedical develops and manufactures reproducible functional micro-tissues for use in toxicity testing, drug screening and ex vivo disease models, and is building methods to assemble these micro-tissues into larger functional macro-tissues for regenerative medicine. The company focuses on automating production platforms, inline/offline quality control and scaling research‑scale processes toward regulated manufacturing.
Explore ReGEN Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.